Genetic variation of the protease and reverse transcriptase genes in HIV-1 CRF04_cpx strains

AIDS Research and Human Retroviruses

Volumn 18, Issue 9, 2002, Pages 677-680

  Papa, Anna ^a   Papadimitriou, Evagelia ^a   Papoutsi, Androniki ^a   Malissiovas, Nikolaos ^a   Kiosses, Vassilios G ^a   Antoniadis, Antonis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PROTEINASE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; MOLECULAR SEQUENCE DATA; POINT MUTATION; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

EID: 0036434122     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202760019392     Document Type: Article

References (15)

1. Hammond J, Calef C, Larder B, Schinazi R, and Mellors JW: Mutations in retroviral genes associated with drug resistance. In: Human Retroviruses and AIDS, Part III. Los Alamos National Laboratory, Los Alamos, New Mexico, 1998, pp. 36-79.
2. Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vezinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S, and Richman DD: Antiretroviral drug resistance testing in adults with HIV infection. JAMA 1998;279:1984-1991.
3. Tanuri A, Vicente AC, Otsuki K, Ramos CA, Ferreira OC Jr, Schechter M, Janini LM, Pieniazek D, and Rayfield MA: Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil. Antimicrob Agents Chemother 1999;43: 253-258.
4. Caride E, Brindeiro R, Hertogs K, Larder B, Dehertogh P, Machado E, de Sa CA, Eyer-Silva WA, Sion FS, Passioni LF, Menezes JA, Calazans AR, and Tanuri A: Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virology 2000;275:107-115.
5. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, and Delaporte E: Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drag resistance mutations in treatment-naive patients. J Clin Microbiol 2000;38:3919 -3925.
6. Sato H, Tomita Y, Shibamura K, Shiino T, Miyakuni T, and Takebe Y: Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies. J Virol 2000;74: 5357-5362.
7. Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, and Ho DD: Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: Identification of a new subtype designated subtype I. J Virol 1995;69:6122-6130.
8. Gao F, Robertson DL, Carmthers CD, Li Y, Bailes E, Kostrikis LG, Salminen MO, Bibollet-Ruche F, Peeters M, Ho DD, Shaw GM, Sharp PM, and Hahn BH: An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J Virol 1998;72:10234-10241.
9. Nasioulas G, Paraskevis D, Magiorkinis E, Theodoridou M, and Hatzakis A: Molecular analysis of the full-length genome of HIV type 1 subtype I: Evidence of A/G/I recombination. AIDS Res Hum Retroviruses 1999;15:745-758.
10. Paraskevis D, Magiorkinis M, Vandamme AM, Kostrikis LG, and Hatzakis A: Reanalysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated "subtype I," reveals a unique complex A/G/H/K/? mosaic pattern. J Gen Virol 2001 ;82:575-580.
11. Papa A, Papadimitriou E, Papoutsi A, Kiosses V, and Antoniadis A: HIV-1 Subtypes and circulating recombinant forms (CRFs) in northern Greece. Virus Res 2002;85:85-93.
12. Vandamme AM, Van Laethem K, and De Clercq E: Managing resistance to anti-HIV drugs: An important consideration for effective disease management. Drugs 1999;57:337-361.
13. Eberle J, Bechowsky B, Rose D, Hauser U, vonder Helm K, Gurtler L, and Nitschko H: Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959. AIDS Res Hum Retroviruses 1995;11:671-676.
14. Molla A, Korneyeva M, Gao Q, Vasavanonda S, Schipper PJ, Mo HM, Markowitz M, Chernyavskiy T, Niu P, Lyons N, Hsu A, Granneman GR, Ho DD, Boucher CA, Leonard JM, Norbeck DW, and Kempf DJ: Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat Med 1996;2:760-766.
15. Condra JH, Holder DJ, Schleif WA, Blahy OM, Danovich RM, Gabryelski LJ, Graham DJ, Laird D, Quintero JC, Rhodes A, Robbins HL, Roth E, Shivaprakash M, Yang T, Chodakewitz JA, Deutsch PJ, Leavitt RY, Massari FE, Mellors JW, Squires KE, Steigbigel RT, Teppler H, and Emini EA: Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol 1996;70:8270-8276.